HAWK CAMBRON: Open Payments
NPI 1144726878 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 17 payments from 8 companies in 2025. Trend: 2023 $264 · 2024 $277 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 3 | $44 |
| Lilly USA, LLC | 3 | $43 |
| ABBVIE INC. | 2 | $29 |
| Novo Nordisk Inc | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: BREZTRI, CAPLYTA, FANAPT, MOUNJARO, VRAYLAR, REXULTI, Kerendia, ZEPBOUND.
Industry payments across LA — which companies pay providers there.
